Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Richard A. Heyman currently holds 22,647 shares of Enliven Therapeutics, Inc. (ELVN), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Richard A. Heyman has been a net seller of ELVN stock. They have purchased $0 and sold $941.4K worth of shares.
Richard A. Heyman's most recent insider trade was on Feb 17, 2026, when they sold 1,230 shares at $26.18 per share.
Richard A. Heyman serves as Executive at Enliven Therapeutics, Inc. (ELVN). They have executed 66 insider transactions totaling $941.4K over their tenure at the company.
Richard A. Heyman holds the position of Executive at Enliven Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 11 years and currently hold a stake valued at $0.
Richard A. Heyman has shown a selling trading pattern, with $0 in total purchases and $941.4K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Richard A. Heyman was on Feb 26, 2024, when they sold $23.0M worth of RYZB shares. This transaction involved 367,446 shares at $62.50 per share.
Richard A. Heyman currently owns 22,647 shares of Enliven Therapeutics, Inc. (ELVN), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Richard A. Heyman's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Richard A. Heyman has 66 Form 4 filings on record as an insider at Enliven Therapeutics, Inc..
Set alerts for Richard A. Heyman and 40,000+ other insiders.